End-of-day quote
Korea S.E.
03:30:00 14/05/2024 am IST
|
5-day change
|
1st Jan Change
|
1,25,300
KRW
|
+2.79%
|
|
-3.02%
|
-4.35%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
4,63,965
|
3,54,442
|
6,01,948
|
8,62,389
|
11,29,730
|
10,80,574
|
-
|
-
|
Enterprise Value (EV)
2 |
703
|
535.9
|
729.1
|
991.7
|
1,16,890
|
1,049
|
935
|
940.1
|
P/E ratio
|
23.9
x
|
15.8
x
|
10.8
x
|
10.1
x
|
11.7
x
|
12.5
x
|
10.5
x
|
8.49
x
|
Yield
|
0.28%
|
0.49%
|
0.36%
|
-
|
0.31%
|
0.27%
|
0.28%
|
0.34%
|
Capitalization / Revenue
|
1.84
x
|
1.54
x
|
2.06
x
|
2.42
x
|
2.87
x
|
2.38
x
|
2.07
x
|
1.78
x
|
EV / Revenue
|
2.79
x
|
2.33
x
|
2.5
x
|
2.79
x
|
297
x
|
2.31
x
|
1.79
x
|
1.55
x
|
EV / EBITDA
|
11.3
x
|
9.86
x
|
8.77
x
|
6.94
x
|
734
x
|
6.11
x
|
4.63
x
|
4.08
x
|
EV / FCF
|
-10.9
x
|
7.98
x
|
15.9
x
|
-173
x
|
5,149
x
|
11
x
|
7.52
x
|
7.25
x
|
FCF Yield
|
-9.14%
|
12.5%
|
6.3%
|
-0.58%
|
0.02%
|
9.06%
|
13.3%
|
13.8%
|
Price to Book
|
2.19
x
|
1.55
x
|
2.06
x
|
2.31
x
|
2.43
x
|
2.33
x
|
1.9
x
|
1.43
x
|
Nbr of stocks (in thousands)
|
8,624
|
8,624
|
8,624
|
8,624
|
8,624
|
8,624
|
-
|
-
|
Reference price
3 |
53,800
|
41,100
|
69,800
|
1,00,000
|
1,31,000
|
1,25,300
|
1,25,300
|
1,25,300
|
Announcement Date
|
27/02/20
|
23/02/21
|
22/03/22
|
28/02/23
|
28/02/24
|
-
|
-
|
-
|
1KRW in Million2KRW in Billions3KRW Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
252.2
|
229.7
|
291.5
|
355.9
|
393.8
|
454.8
|
522.2
|
607.3
|
EBITDA
1 |
62.23
|
54.33
|
83.09
|
142.9
|
159.2
|
171.5
|
201.8
|
230.7
|
EBIT
1 |
47.92
|
39.6
|
69.88
|
124.4
|
131.9
|
151.5
|
181.1
|
211
|
Operating Margin
|
19%
|
17.23%
|
23.97%
|
34.95%
|
33.49%
|
33.31%
|
34.68%
|
34.74%
|
Earnings before Tax (EBT)
1 |
38.01
|
26.05
|
74.72
|
117.5
|
123.9
|
146.7
|
176.5
|
218
|
Net income
1 |
18.33
|
22.54
|
55.48
|
85.15
|
89.55
|
112.4
|
131.5
|
163.5
|
Net margin
|
7.27%
|
9.81%
|
19.03%
|
23.93%
|
22.74%
|
24.72%
|
25.19%
|
26.92%
|
EPS
2 |
2,250
|
2,595
|
6,434
|
9,873
|
11,193
|
10,036
|
11,883
|
14,766
|
Free Cash Flow
3 |
-64,236
|
67,140
|
45,932
|
-5,722
|
22,701
|
95,000
|
1,24,350
|
1,29,667
|
FCF margin
|
-25,474.1%
|
29,223.07%
|
15,755.39%
|
-1,608.01%
|
5,764.82%
|
20,888.96%
|
23,814.43%
|
21,350.16%
|
FCF Conversion (EBITDA)
|
-
|
1,23,574.12%
|
55,280.69%
|
-
|
14,262.74%
|
55,393.59%
|
61,620.42%
|
56,213.87%
|
FCF Conversion (Net income)
|
-
|
2,97,807.54%
|
82,783.48%
|
-
|
25,350.16%
|
84,489.51%
|
94,531.93%
|
79,306.83%
|
Dividend per Share
2 |
150.0
|
200.0
|
250.0
|
-
|
400.0
|
333.3
|
354.3
|
426.7
|
Announcement Date
|
27/02/20
|
23/02/21
|
22/03/22
|
28/02/23
|
28/02/24
|
-
|
-
|
-
|
1KRW in Billions2KRW3KRW in Million Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
71.17
|
94.07
|
74.53
|
96.67
|
90.66
|
94.02
|
68.81
|
106.4
|
93.78
|
124.8
|
82.73
|
115.8
|
111.2
|
139.3
|
EBITDA
1 |
-
|
-
|
-
|
-
|
38.25
|
39.84
|
26.38
|
37.44
|
-
|
-
|
28.9
|
47
|
41.3
|
54.8
|
EBIT
1 |
15.1
|
27.27
|
20.4
|
35.2
|
33.72
|
35.07
|
21.53
|
33.75
|
30.06
|
47.89
|
19.22
|
39.9
|
37.8
|
50.13
|
Operating Margin
|
21.22%
|
28.99%
|
27.37%
|
36.41%
|
37.2%
|
37.3%
|
31.29%
|
31.73%
|
32.05%
|
38.37%
|
23.23%
|
34.46%
|
33.98%
|
35.99%
|
Earnings before Tax (EBT)
1 |
18.44
|
27.04
|
21.84
|
40.99
|
37.44
|
17.26
|
23.71
|
30.47
|
30.01
|
41.04
|
18.68
|
-
|
-
|
-
|
Net income
1 |
14.06
|
18.53
|
15.68
|
36.14
|
24.53
|
8.794
|
18.32
|
21.17
|
24.07
|
27.02
|
16.71
|
28.12
|
27.15
|
37.25
|
Net margin
|
19.76%
|
19.7%
|
21.04%
|
37.39%
|
27.06%
|
9.35%
|
26.62%
|
19.9%
|
25.66%
|
21.65%
|
20.2%
|
24.29%
|
24.4%
|
26.74%
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
04/11/21
|
22/03/22
|
09/05/22
|
08/08/22
|
08/11/22
|
28/02/23
|
09/05/23
|
08/08/23
|
08/11/23
|
28/02/24
|
09/05/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
239
|
181
|
127
|
129
|
1,15,761
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
31.9
|
146
|
141
|
Leverage (Debt/EBITDA)
|
3.841
x
|
3.34
x
|
1.53
x
|
0.9048
x
|
727.3
x
|
-
|
-
|
-
|
Free Cash Flow
2 |
-64,236
|
67,140
|
45,932
|
-5,722
|
22,701
|
95,000
|
1,24,350
|
1,29,667
|
ROE (net income / shareholders' equity)
|
9.03%
|
10.3%
|
21.7%
|
25.7%
|
23%
|
22.3%
|
20.9%
|
20.6%
|
ROA (Net income/ Total Assets)
|
3.71%
|
4.26%
|
10.3%
|
13.8%
|
13.3%
|
14.7%
|
14.9%
|
16.7%
|
Assets
1 |
494.1
|
528.7
|
540.2
|
615.7
|
671.9
|
767.1
|
882.8
|
981
|
Book Value Per Share
3 |
24,522
|
26,588
|
33,841
|
43,354
|
53,874
|
53,692
|
65,857
|
87,539
|
Cash Flow per Share
3 |
-1,513
|
8,727
|
8,594
|
5,451
|
7,536
|
16,360
|
17,146
|
21,696
|
Capex
1 |
51.2
|
8.62
|
28.2
|
52.7
|
42.3
|
29.1
|
33.8
|
37.5
|
Capex / Sales
|
20.3%
|
3.75%
|
9.67%
|
14.82%
|
10.74%
|
6.39%
|
6.47%
|
6.17%
|
Announcement Date
|
27/02/20
|
23/02/21
|
22/03/22
|
28/02/23
|
28/02/24
|
-
|
-
|
-
|
1KRW in Billions2KRW in Million3KRW Last Close Price
1,25,300
KRW Average target price
1,71,625
KRW Spread / Average Target +36.97% Consensus |
1st Jan change
|
Capi.
|
---|
| -4.35% | 769M | | +8.29% | 124B | | -5.61% | 11.02B | | +4.83% | 8.88B | | +39.60% | 5.45B | | -22.04% | 4.74B | | +8.39% | 3.44B | | -6.28% | 2.84B | | -10.23% | 2.15B | | -5.99% | 2.11B |
Medical Devices & Implants
|